Cart
sales@molnova.com
ML 315
CAS No. 1440251-53-5
ML 315( —— )
Catalog No. M34876 CAS No. 1440251-53-5
ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 756 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1516 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML 315
-
NoteResearch use only, not for human use.
-
Brief DescriptionML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
-
DescriptionML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDYRK | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1440251-53-5
-
Formula Weight374.22
-
Molecular FormulaC18H13Cl2N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC=1C=C(Cl)C=C(C1)CNC=2N=CN=CC2C3=CC=C4OCOC4=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3654-61.?
molnova catalog
related products
-
3-Amino-4-hydroxyben...
3-Amino-4-hydroxybenzoic acid is a useful research chemical.
-
N-[(4-methylphenyl)c...
N-[(4-methylphenyl)carbamothioyl]-2-nitrobenzamide can be used in the synthesis of N-aryl-N'-(o-nitrobenzoyl)thiourea derivatives and related research.
-
Nigakinone
Nigakinone, isolated from Kumu, is an alkaloid with the pharmacological activity.
